Navigation Links
Topaz Pharmaceuticals Announces Completion of Pivotal Phase 3 Trials of Ivermectin Topical Cream
Date:12/7/2010

HORSHAM, Pa., Dec. 7, 2010 /PRNewswire/ -- Topaz Pharmaceuticals Inc., a privately held specialty pharmaceutical company, today announced the completion of two Phase 3 clinical trials that studied the use of ivermectin topical cream as a potential treatment for head lice. These trials were conducted according to a Special Protocol Assessment (SPA) agreement with the Food and Drug Administration (FDA).

"Parents and caregivers are looking for safe and effective treatments for head lice," said Thomas Beck, MD, Chief Medical Officer at Topaz.  "Current treatment options are limited by safety, efficacy and convenience issues.  We believe there is an unmet need to provide a new option for the more than six million people, mostly school aged children who are impacted by lice each year in the US.  The completion of our two Phase 3 clinical trials is a critical milestone in our development of ivermectin topical cream as a potential head lice treatment and for Topaz, as we continue to move closer to realizing our vision of being a commercial-stage company."

Topaz plans to submit its new drug application (NDA) to the FDA in 2011.

About the Phase 3 Ivermectin Cream ProgramMore than 600 patients participated in the two randomized Phase 3 ivermectin topical cream studies sponsored by Topaz.  These studies compared 0.5% ivermectin cream with a vehicle control (placebo).  Either ivermectin topical cream or placebo was dispensed to clinical trial participants six months of age and older for application to dry hair and scalp.  The primary efficacy endpoint for these studies was achieving "lice free" status within approximately 24 hours of application and maintaining this status for at least 14 days after application.  Patients were also evaluated for safety and local tolerability.  These studies were conducted in follow-up to favorable Phase 2 clinical studies that were presented by researchers in July 2010 at the
'/>"/>

SOURCE Topaz Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer
2. TOPAZ Technologies and ML Weekes & Company Announce Partnership
3. Shareholder Class Action Filed Against SciClone Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
4. Topaz Pharmaceuticals Announces Positive Data from Topical Ivermectin Trials Presented at Society of Pediatric Dermatology
5. TOPAZ Technologies and Tecniplast USA Launch RFID Mobile Census
6. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
7. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
8. Schiffrin Barroway Topaz & Kessler, LLP and Janet Jenner & Suggs, LLC Comment on Conagra Advisory Regarding Pot Pies Linked to Salmonella Outbreak
9. HemaQuest Pharmaceuticals, Inc. Presents Promising Clinical Results at 52nd Annual Meeting of the American Society of Hematology (ASH)
10. Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine)
11. Portola Pharmaceuticals Announces Data Presentations Highlighting Syk/JAK Inhibitor Clinical Development Program at 52nd American Society of Hematology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 2015 /OFF HOLD OFF ... PIV757417 The following release: "Biotech Advancements Coupled with ... & Treatments for Critical-Care Patients With Severe Wound ... Aug 2015 12:30 GMT Cooperative research ... research and top-tier universities for identifying biotech solutions ...
(Date:8/3/2015)...  Charleston Laboratories, Inc., an emerging specialty pharmaceutical ... program with a Phase 1 study on its ... contains fast-dissolving promethazine and sumatriptan.  This novel migraine ... migraine headache pain and migraine-induced nausea and vomiting ... headaches also suffer from nausea and vomiting," said ...
(Date:8/3/2015)... , August 3, 2015 BiondVax ... the statistical analysis of results from a study which demonstrates ... phase II trial which took place in 2012, provided participants ... at the time of the study- in particular the current ... in the United States in 2015. ...
Breaking Medicine Technology:/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 3/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 4/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 5/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 6Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 3
... N.J., May 7 In letters to Senate Special ... Finance Committee Ranking Member Charles Grassley (R-IA), Johnson & ... Sunshine Act of 2009 (S. 301). The company also ... by its U.S. pharmaceutical, medical device and diagnostics companies."We ...
... at American Pain Society Annual Meeting-BALTIMORE, May 7 ... stage biotechnology company that develops pain therapies, today ... lead candidate, ARC-4558, significantly reduced pain caused by ... abstract will be presented in a poster session ...
Cached Medicine Technology:Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009 2Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009 3Arcion Therapeutics' Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy 2Arcion Therapeutics' Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy 3
(Date:8/3/2015)... ... 2015 , ... To date, many pharmaceutical and biotech companies ... benefits, allowing them to gain access to capabilities that cannot be found in-house, ... get access to innovation and ensure timely introduction of product into the market. ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... largest online retailer of nutritional supplements, has officially opened the polls for ... awards in the following categories:, ,     Brand of the ...
(Date:8/3/2015)... ... 2015 , ... The art of preparing and cooking food comes naturally to ... young age, Nasreen Zereshki was extremely eager to cook Persian cuisine. Now that she ... My Persian Kitchen with the world. , Since Americans tend to be undereducated about ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... to Ahjumawi Lava Springs, California’s northernmost and among its least visited State Parks. ... water aquifers, whose main outflow is at Ahjumawi Lava Springs, part of the ...
(Date:8/3/2015)... ... 2015 , ... From 2006-2017 the number of dental laboratories ... research compiled for the National Association of Dental Laboratories ( NADL ) by ... Labor Statistics. As the number of dental laboratories decreases, dentists will have fewer ...
Breaking Medicine News(10 mins):Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 2Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 3Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 2Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 2Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 3
... by Television Week for providing "vital information" to ... television program that tells the compelling and inspirational stories of ... markets: Denver, CO; Albany, NY; Austin, TX; Salt Lake City, ... all, the program now airs on nearly 260 television stations ...
... Improve Your Heart Health Through Proper Oral Care WASHINGTON, ... throughout the U.S. will be making personal pledges to ... initiative and promote heart health awareness, WomenHeart has partnered ... campaign. Heart Promises will focus on empowering ...
... Was Financially Untenable -LOS ANGELES, Feb. 9 According ... explanations offered for the closing of the Motion Picture ... up, raising questions about the underlying reasons for displacing ... live out their lives at the facility.The story by ...
... to learn about Heart Failure-how to prevent it and to ... Week February 8-14, 2009 Heart Failure Society of ... Available at www.abouthf.org NEW YORK, ... for February 8-14. This is a time for ...
... 9 Global multiservice public relations,agency Waggener ... panel discussion,titled "Healthcare Communications in the Digital ... Environment." The presentation will take place on,Tuesday, ... company,s Washington, D.C., office and be,available via ...
... to Discuss Results - EXTON, Pa., Feb. 9 ... that its Phase 3 trial evaluating maribavir used as ... (SCT) patients did not achieve its primary endpoint. In ... between maribavir and placebo in reducing the rate of ...
Cached Medicine News:Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 2Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 3Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 4Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 5Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 6Health News:WomenHeart Celebrates American Heart Month With Heart Promises Campaign 2Health News:WomenHeart Celebrates American Heart Month With Heart Promises Campaign 3Health News:WomenHeart Celebrates American Heart Month With Heart Promises Campaign 4Health News:National Heart Failure Awareness Week February 8-14, 2009: Visit www.abouthf.org to Learn More About Heart Failure 2Health News:National Heart Failure Awareness Week February 8-14, 2009: Visit www.abouthf.org to Learn More About Heart Failure 3Health News:Healthcare Online Regulations Discussed in Live Event and Webcast Hosted by Waggener Edstrom Worldwide 2Health News:ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients 2Health News:ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients 3Health News:ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients 4Health News:ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: